Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapy \High Risk Prostate Cancer”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)UnknownNCT05076851
What this trial is testing

Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

Who this might be right for
Neoadjuvant Therapy \High Risk Prostate Cancer
Hongqian Guo 2
Testing effectiveness (Phase 2)WithdrawnNCT04565496
What this trial is testing

Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients

Who this might be right for
Prostate Cancer
IRCCS San Raffaele
Testing effectiveness (Phase 2)Active Not RecruitingNCT05498272
What this trial is testing

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

Who this might be right for
Prostate CancerBRCA1 MutationBRCA2 Mutation+2 more
Rana McKay, MD 32
Testing effectiveness (Phase 2)Ended earlyNCT00577356
What this trial is testing

Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Benaroya Research Institute 6
Testing effectiveness (Phase 2)UnknownNCT00657982
What this trial is testing

Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sheba Medical Center 15
Early research (Phase 1)Study completedNCT02946008
What this trial is testing

Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 17
Not applicableNot Yet RecruitingNCT07311915
What this trial is testing

Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study

Who this might be right for
Prostate Cancer
Zhongda Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00828308
What this trial is testing

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Brown University 16
Testing effectiveness (Phase 2)Ended earlyNCT01941550
What this trial is testing

Neoadjuvant Chemotherapy With Cabazitaxel

Who this might be right for
High-Risk Cancer
RWTH Aachen University 11
Testing effectiveness (Phase 2)Ended earlyNCT03886493
What this trial is testing

Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 7
Not applicableUnknownNCT00870714
What this trial is testing

Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study

Who this might be right for
Prostate Cancer
Kansas City Veteran Affairs Medical Center 20
Very early researchStudy completedNCT01804712
What this trial is testing

Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy

Who this might be right for
Prostate Cancer
Christopher Kane 8
Testing effectiveness (Phase 2)UnknownNCT06029036
What this trial is testing

A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Peking University First Hospital 53
Testing effectiveness (Phase 2)Looking for participantsNCT05406999
What this trial is testing

Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer

Who this might be right for
Neoadjuvant TherapyHigh Risk Prostate CancerLocally Advanced Prostate Cancer+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 900
Testing effectiveness (Phase 2)Ended earlyNCT00860158
What this trial is testing

Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Noah Hahn, M.D. 1
Testing effectiveness (Phase 2)Study completedNCT02903368
What this trial is testing

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT02949284
What this trial is testing

Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Rutgers, The State University of New Jersey 90
Early research (Phase 1)Looking for participantsNCT06130995
What this trial is testing

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Who this might be right for
Androgen Deprivation TherapyLocally Advanced Prostate Cancer
University of Oklahoma 46
Testing effectiveness (Phase 2)Ended earlyNCT04737109
What this trial is testing

Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer

Who this might be right for
Castrate Resistant Prostate Cancer
David VanderWeele 6
Not applicableLooking for participantsNCT04894188
What this trial is testing

Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 38
Next Page